Double-blind evaluation of clonazepam on periodic leg movements in sleep.

AUTOR(ES)

Peled, R

RESUMO

Treatment with clonazepam was studied in a group of 20 patients suffering from periodic movements in sleep, in a double-blind parallel group design. Eleven complained of excessive daytime sleepiness, and nine complained of insomnia. Ten patients received clonazepam, and 10 received placebo, over a period of 1 month. Clonazepam (0.5-2 mg per night) proved to be an effective treatment of periodic movements in sleep. Polysomnographic recordings demonstrated a significant decrease in the number of leg movements and a significant improvement in sleep parameters in the clonazepam group as compared with placebo. Subjective responses to treatment corroborated the sleep laboratory findings.

Documentos Relacionados

• A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania
• Prospective Double-Blind Evaluation of Topical Adenine Arabinoside in Male Herpes Progenitalis
• Naproxen in osteoarthrosis. Double-blind crossover trial.
• Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.
• Penotrane in blepharitis. A double-blind controlled trial.